Lafleur Godfrey buys $10,719,233 stake in Stryker Corporation (SYK)

Stryker Corporation (SYK) : Lafleur Godfrey scooped up 502 additional shares in Stryker Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 10, 2016. The investment management firm now holds a total of 92,751 shares of Stryker Corporation which is valued at $10,719,233.Stryker Corporation makes up approximately 3.02% of Lafleur Godfrey’s portfolio.

Other Hedge Funds, Including , Clifford Swan Investment Counsel reduced its stake in SYK by selling 7,361 shares or 4.02% in the most recent quarter. The Hedge Fund company now holds 175,840 shares of SYK which is valued at $20,321,829. Stryker Corporation makes up approx 1.37% of Clifford Swan Investment Counsel’s portfolio.Dekabank Deutsche Girozentrale boosted its stake in SYK in the latest quarter, The investment management firm added 4,867 additional shares and now holds a total of 187,121 shares of Stryker Corporation which is valued at $21,500,203. Stryker Corporation makes up approx 0.23% of Dekabank Deutsche Girozentrale’s portfolio.John G Ullman Associates Inc reduced its stake in SYK by selling 200 shares or 1.67% in the most recent quarter. The Hedge Fund company now holds 11,800 shares of SYK which is valued at $1,380,954. Stryker Corporation makes up approx 0.27% of John G Ullman Associates Inc’s portfolio.Barrett Asset Management reduced its stake in SYK by selling 1,990 shares or 0.83% in the most recent quarter. The Hedge Fund company now holds 238,026 shares of SYK which is valued at $29,124,861. Stryker Corporation makes up approx 2.43% of Barrett Asset Management’s portfolio.

Stryker Corporation opened for trading at $113.32 and hit $113.8 on the upside on Friday, eventually ending the session at $113.77, with a gain of 0.02% or 0.02 points. The heightened volatility saw the trading volume jump to 8,81,320 shares. Company has a market cap of $42,584 M.

On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.

Investors should note that on Jul 27, 2016, Stryker Corporation announced a cash dividend of $0.3800. The company’s management has announced Sep 28, 2016 as the ex-dividend date and fixed the record date on Sep 30, 2016. The payable date has been fixed on Oct 31, 2016.

Many Wall Street Analysts have commented on Stryker Corporation. Stryker Corporation was Initiated by Guggenheim to “Buy” on Jun 9, 2016.

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.

Leave a Reply

Stryker Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Stryker Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.